Diagnostics post-COVID19: what's needed and what are the opportunities?

HIRANI Interim CEO, Dr Rob Grundy, was joined in discussion by Ulster University’s Prof Tara Moore, HSC’s Dr Maurice O’Kane, Almac’s Prof Richard Kennedy and Medicines Discovery Catapult’s Prof Chris Molloy. Panel discussion focused on how COVID-19 has changed diagnostics and what opportunities might lie ahead for clinical practice, research and industry.

Watch the video